Skip to content

A study to explore and compare the effectiveness of Vidaryadi Kwatha and Gokshuradi Guggulu in participants suffering from Pittaj Mutrakruchhra (urinary tract infection), focusing on relief from urinary symptoms such as burning micturition, pain, and frequency of urination.

A Randomized clinical trial to compare the efficacy of Vidaryadi Kwatha with Gokshuradi Guggulu in the management of Pittaj Mutrakruchhra with special reference to Urinary tract infection - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/03/105192
Enrollment
70
Registered
2026-03-02
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N390- Urinary tract infection, site notspecified

Interventions

None listed

Sponsors

Dr. Prerna Suresh Bhandarkar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients having sign and symptoms of Pittaj Mutrakruchhra (Sadaha, Sapeet, Saruja Mutraprovruti). 2. Age group between 25 to 60 years. 3. Patients irrespective of religion, sex, and economical status. 4. Patients having recurrent UTI.

Exclusion criteria

Exclusion criteria: 1.Pregnancy & lactation 2.Prostate enlargement 3.Known case of Malignancy of any part of urinary tract. 4.Phimosis or paraphimosis 5.Known case of Renal failure, Chronic kidney diseases, Renal calculus, Renal cyst. 6.Sever Traumatic causes 7.Known case of Uncontrolled diabetes 8.Nephritis, Pyelonephritis, Chronic nephrotic syndrome. 9.Complicated UTI, moderate to severe and continuous bleeding during micturition. 10. Any severe co-morbidity

Design outcomes

Primary

MeasureTime frame
1.To study the efficacy of Vidaryadi Kwatha in the management of Pittoj Mutrakruchhra. 2. To study the efficacy of Gokshuradi Guggulu in the management of Pittaj Mutrakruchhra.Timepoint: On the day 0, day 7, day 14 and day 21.

Secondary

MeasureTime frame
1.To explore the samprapti, samprapti ghatak and chikitsaupakram of Pittaj Mutrakruchhra. 2.To study Ayurvedic and Modern aspect regarding etiopathogenesis of Pittaj Mutrakruchhra with special reference to urinary tract infection. 3.To provide easily available, better, and safe treatment for Pittaj Mutrakruchhra. 4.To observe adverse effect, If any. 5.To study the drugs in detail.Timepoint: On the day 0, day 7, day 14 and day 21.

Countries

India

Contacts

Public ContactDr Prerna Suresh Bhandarkar

Dr. Rajendra Gode Ayurved College Hospital and Research Centre Amravati

lpanks48@gmail.com9970599134

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026